advertisement
Ranshing S 27
Showing records 1 to 25 | Display all abstracts from Ranshing S117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Patil SV
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Patil SV; Kaipa BR
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Kaipa BR
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Kaipa BR
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Kaipa BR; Ranshing S
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Ranshing S
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Ranshing S
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Ranshing S; Sundaresan Y
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Sundaresan Y; Millar JC
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Millar JC
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Nagarajan B
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Nagarajan B
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Kiehlbauch C
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Kiehlbauch C; Zhang Q
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Zhang Q
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Jain A
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Jain A
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Searby CC
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Searby CC
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Scheetz TE
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Scheetz TE
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Clark AF
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Clark AF
Research square 2023; 0:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Sheffield VC
Scientific reports 2024; 14: 6958
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Sheffield VC
Research square 2023; 0:
